Stoke Therapeutics, Inc.
STOK· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
no prior Q3 2017 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Stoke Therapeutics, Inc. · CIK 1623526 · Engraved from SEC EDGAR